JPMorgan Starts Kyverna Therapeutics Inc (KYTX) at Overweight, 'A Compelling Cell Therapy Play'
Tweet Send to a Friend
(Updated - March 4, 2024 3:51 AM EST)
JPMorgan analyst Brian Cheng initiates coverage on Kyverna Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Brian Cheng initiates coverage on Kyverna Therapeutics Inc (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
